language Türkçe
Article Early Access 2022 · 0 citations

Decreased Na<SUP>+</SUP>/K<SUP>+</SUP> pump activity in the erythrocyte membrane due to malondialdehyde in rheumatoid arthritis: an in vivo and in silico study

Ogul, Yasemin, Gur, Fatma, Gur, Bahri, Cengiz, Mustafa, Sari, Refik Ali, Kiziltunc, Ahmet

Abstract

Apart from demonstrating the interaction behavior of malondialdehyde (MDA) with Na+/K+-ATPase using in silico, the current study aims to investigate the effect of rheumatoid arthritis-related oxidative stress on Na+/K+-ATPase activity that is present in the erythrocyte cell membrane, which is rich in proteins vulnerable to damage from MDA and other free radicals. The target population of this study consists of 28 rheumatoid arthritis patients and 20 healthy volunteers whose MDA levels and Na+/K+-ATPase activity were determined. It was shown that MDA levels of rheumatoid arthritis patients increased (p < 0.001) and their Na+/K+-ATPase activity noticeably decreased when compared to those of healthy individuals. Also, according to this in silico modeling, MDA decreased Na+/K+-ATPase activity in line with the correlation analyses. Consequently, while elevated levels of MDA in the rheumatoid arthritis group were suggestive of oxidative stress, a decreased Na+/K+-ATPase-activity led us to speculate that the cellular membrane had sustained injury. Therefore, our results could be useful in explaining how MDA affects Na+/K+-ATPase activity in the interior of a specific molecular pathway.

Keywords
Na+/K+-ATPase activity rheumatoid arthritis lipid peroxidation negative binding energy molecular docking SUPEROXIDE-DISMUTASE ANTIOXIDANT STATUS SODIUM PATHOGENESIS DOCKING ELUCIDATION INHIBITION OXIDATION CATALASE
WoS Categories
Pharmacology & Pharmacy Physiology
Sustainable Development Goals
Citation
Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Year
2022
ISSN
0008-4212
eISSN
1205-7541
DOI
10.1139/cjpp-2022-0171
WoS UID
WOS:000861089600001
Open via DOI